Current Edition

FDA Focuses on Technology Modernisation Efforts

Under new leadership, the US Food and Drug Administration (FDA) is now focusing efforts on closing the gap between scientific advances and the computing solutions needed to translate advances into new therapies for patients, through the agency’s Technology Modernisation Action Plan (TMAP). Molly Spence at Clarivate Analytics emphasises the FDA’s focus on technology modernisation efforts in detail.